Cancer heterogeneity is a result of genetic mutations within the cancer cells. Their proliferation is not only driven by autocrine functions but also under the influence of cancer microenvironment, which consists of normal stromal cells such as infiltrating immune cells, cancer-associated fibroblasts, endothelial cells, pericytes, vascular and lymphatic channels. The relationship between cancer cells and cancer microenvironment is a critical one and we are just on the verge to understand it on a molecular level. Cancer microenvironment may serve as a selective force to modulate cancer cells to allow them to evolve into more aggressive clones with ability to invade the lymphatic or vascular channels to spread to regional lymph nodes and dist...
Cancer progression is an evolutionary process. During this process, evolving cancer cell populations...
The role of the microenvironment in cancer development is being increasingly appreciated. This paper...
The major clinical challenge of systemic cancer therapy is not eradication of the primary tumor, whi...
Cancer heterogeneity is a result of genetic mutations within the cancer cells. Their proliferation i...
The development of cancer begins with cells transitioning from their multicellular nature to a state...
Cancer Cell & Microenvironment is an open access, peer-reviewed, online journal that encompasses all...
Cancers represent complex ecosystems comprising tumor cells and a multitude of non-cancerous cells, ...
Cancer cells acquire cell-autonomous capacities to undergo limitless proliferation and survival thro...
Cancer cells acquire cell-autonomous capacities to undergo limitless proliferation and survival thro...
Abstract Analysis of spatial and temporal genetic heterogeneity in human cancers has revealed that s...
Precision medicine requires an understanding of cancer genes and mutational processes, as well as an...
A common cause of all cancers leads us to a common definition. This definition is mutation. Cancer c...
While it is widely acknowledged that intratumor heterogeneity is mostly generated by genomic instabi...
Tumor cells able to recapitulate tumor heterogeneity have been tracked, isolated and characterized i...
Cancer is a multifactorial Disorder caused by variations in multiple genes coupled with environmenta...
Cancer progression is an evolutionary process. During this process, evolving cancer cell populations...
The role of the microenvironment in cancer development is being increasingly appreciated. This paper...
The major clinical challenge of systemic cancer therapy is not eradication of the primary tumor, whi...
Cancer heterogeneity is a result of genetic mutations within the cancer cells. Their proliferation i...
The development of cancer begins with cells transitioning from their multicellular nature to a state...
Cancer Cell & Microenvironment is an open access, peer-reviewed, online journal that encompasses all...
Cancers represent complex ecosystems comprising tumor cells and a multitude of non-cancerous cells, ...
Cancer cells acquire cell-autonomous capacities to undergo limitless proliferation and survival thro...
Cancer cells acquire cell-autonomous capacities to undergo limitless proliferation and survival thro...
Abstract Analysis of spatial and temporal genetic heterogeneity in human cancers has revealed that s...
Precision medicine requires an understanding of cancer genes and mutational processes, as well as an...
A common cause of all cancers leads us to a common definition. This definition is mutation. Cancer c...
While it is widely acknowledged that intratumor heterogeneity is mostly generated by genomic instabi...
Tumor cells able to recapitulate tumor heterogeneity have been tracked, isolated and characterized i...
Cancer is a multifactorial Disorder caused by variations in multiple genes coupled with environmenta...
Cancer progression is an evolutionary process. During this process, evolving cancer cell populations...
The role of the microenvironment in cancer development is being increasingly appreciated. This paper...
The major clinical challenge of systemic cancer therapy is not eradication of the primary tumor, whi...